(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AKAMIS BIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AKAMIS BIO

ST13

US500000097823138

Class

5, 35, 42

Filing

97823138

Registration

7554922

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

04/23/2026

Trademark type

Combined

Nice classes

5, 35, 42

Filing date

03/04/2023

Registration date

11/05/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/05/2024

Last transaction

04/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

03

Owner location

CAMBRIDGE, MA, US

Examiner

JARAMILLO, JAVIER R

Law office

M70

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "AKAMIS BIO" to the right of a design consisting of a circle containing a hexagon with a curving paint brushstroke to the upper left.

Holders and representatives

Holders

AKAMIS BIO, INC.
Akamis Bio Limited

Representatives

Brian J. Focarino Cooley LLP

Technical classification

Nice Classes

Class 5Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; biotechnological preparations for the medical treatment of solid tumors; biotechnological preparations for the treatment of oncological diseases and disorders

Class 35

Marketing services in the field of pharmaceutical products; product marketing services in the field of pharmaceutical products; market research in the field of pharmaceutical products; market forecasting in the field of pharmaceutical products; market evaluation servicesmarket analysis and research services in the field of pharmaceutical products; online retail and wholesale store services for pharmaceutical products; online retail and wholesale store services for pharmaceutical preparations; advisoryinformation and consultancy services relating to the aforementioned services

Class 42

Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development service; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; scientific and medical research in the nature of genome organization and functional analysis; genetic testing for scientific research purposes; research and development services in the field of immunologybiotechnologyoncologymedicinegene therapyimmunotherapy and therapeutics; technological consulting servicesproduct development consultation relating to the manufacture of pharmaceuticals; technological consulting servicesproduct development consultation relating to the design of manufacturing methods for pharmaceuticals; advisoryinformation and consultancy services relating to the aforementioned services

Publications

History of USPTO decisions and trademark events.

32 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/22/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/11/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/11/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/11/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/11/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/11/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/05/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/20/2024

PUBO

PUBLISHED FOR OPPOSITION

08/20/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/31/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/17/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

07/17/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/17/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

07/17/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/17/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/16/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/16/2024

ALIE

ASSIGNED TO LIE

07/16/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/26/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/11/2023

GNRT

NON-FINAL ACTION E-MAILED

12/11/2023

CNRT

NON-FINAL ACTION WRITTEN

12/11/2023

DOCK

ASSIGNED TO EXAMINER

12/01/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/27/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/27/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/27/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/27/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/25/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/24/2023

NWAP

NEW APPLICATION ENTERED

03/08/2023

Continuous trademark protection

Get notified about every new filing that threatens AKAMIS BIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.